current price
1.81 | 1.06%
1.81 | 1.06%
Yesterday's Close
5.02 M
30d. avg volume.
6.59 M
1 day
170.38 - 172.18
52 weeks
133.65 - 173.65
market cap
452.39 B
dividend yield
News and Commentary
Market Update: Stocks Continue Comeback From Monday's Rout Stocks climbed higher Wednesday as the broader market moved to continue its comeback from the one-day plunge at the start of the week. All three benchmarks rose higher, with the...
Biden Walks Back Facebook Comments, but Continues to Pressure Tech Companies to Curb Vaccine Misinfo... President Joe Biden retracted some of his previous criticisms of Facebook
J&J Recalls 5 Neutrogena, Aveeno Sunscreens Due to Carcinogen Traces Johnson & Johnson (JNJ&...
Market Update: S&P 500 Dips Lower Despite Strong Start to Q2 Earnings Season The S&P 500 slipped into the red on Thursday despite the second-quarter earnings season starting off strongly. Wall Street ended the session mixed, with the Dow Jones climbing sl...
FDA Warns Johnson & Johnson Vaccine Possibly Linked to Rare Neurological Condition The Food and Drug Administration (FDA) announced revisions to Johnson &...
Pfizer Meets with U.S. Health Officials to Push Third COVID Booster Shot Pfizer (PFE 
Virtually All COVID Hospitalizations and Deaths in U.S. are Among Unvaccinated Americans The vast majority of COVID-19 hospitalizations and deaths are occurring among people who are unvaccinated, White House officials stated Thursday."Virtua...
Biden Outlines Targeted National Vaccination Strategies After Missing 70% Goal Failing to meet his self-imposed July 4 vaccination goal, President Joe Biden outlined several strategies earlier this week to help persuade more Americans to get vaccinated agai...
The White House is Deploying COVID Response Teams to Combat Delta Variant The Biden administration is deploy COVID-19 response teams across the United States focused on tracking and tracing the nation's outbreak of the highly transmissible Delta varian...
Mix and Matching AstraZeneca and Pfizer Vaccines Produces Strong Immune Response, says Oxford Study Mixing and matching the dosing regimens for the coronavirus vaccines developed by Pfizer

Join now and unlock premium features